B-cell Non-hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma [Phase 1]

  It notes the completion of a Phase I trial evaluating the continuous infusion immunotoxin IgG-RFB4-SMPT-dgA in refractory CD22-positive B-ce…

• CLINICAL_TRIALS trial_result · 2008-01-28
  Clinical Trial Update: Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 2]

  A Phase 2 trial of bortezomib combined with rituximab for relapsed or refractory B-cell non-Hodgkin's lymphoma was terminated.